According to GuruFocus' Insider Data, the recent CFO buys were: Neogen Corp. (NEOG, Financial), Medical Transcription Billing Corp. (MTBC, Financial) and EVINE Live Inc. (EVLV, Financial).
Neogen: V.P. and CFO Steven J. Quinlan bought 2,236 shares
On March 24, V.P. and CFO Steven J. Quinlan bought 2,236 shares at an average price of $44.73. The price of the stock has increased by 8.23%.
Neogen has a market cap of $1.82 billion, and its shares were traded around $47.5 Tuesday. The company has a P/E ratio of 50.43 and P/S ratio of 6.06. Over the past 10 years, Neogen had an annual average earnings growth of 17.00%. GuruFocus rated Neogen the business predictability rank of 4.5-star.
Neogen announced its 2015 fourth-quarter results with revenues of $79.61 million and gross profit of $38.22 million; the net income was $9.07 million. The 2015 total revenue was $283.07 million, a 14% increase from the 2014 total revenue. The 2015 gross profit was $139.69 million, a 14% increase from the 2014 gross profit. The 2015 net income was $33.53 million.
On March 17, Chairman and CEO James L. Herbert sold 2,500 shares at an average price of $49.05. The price of the stock has decreased by 1.3%. On Jan. 28, Director Jack C. Parnell bought 13 shares at an average price of $50.25. The price of the stock has decreased by 3.66%. On Jan. 29, Vice President Terri A. Morrical sold 4,677 shares at an average price of $51.13. The price of the stock has decreased by 5.32%.
Medical Transcription Billing: CFO Bill Korn bought 5,000 shares
On March 29, CFO Bill Korn bought 5,000 shares at an average price of $1.06. The price of the stock has decreased by 3.77%. Medical Transcription Billing has a market cap of $10.54 million, and its shares were traded around $1.02. The company has a P/S ratio of 0.43.
Medical Transcription Billing announced its 2015 fourth-quarter results with revenues of $5.36 million and gross profit of $3.01 million; the net loss was $801,000. The 2015 total revenue was $23.08 million, a 26% increase from the 2014 total revenue. The 2015 gross profit was $11.45 million, a 49% increase from the 2014 gross profit. The 2015 net loss was $4.69 million.
On Nov. 30, CEO Mahmud Ul Haq bought 20,000 shares at an average price of $1.34. The price of the stock has decreased by 23.88%. On Nov. 30, President Stephen Andrew Snyder bought 5,000 shares at an average price of $1.33. The price of the stock has decreased by 23.31%.
EVINE Live: CFO Tim Peterman bought 162,000 shares
On March 28, CFO Tim Peterman bought 162,000 shares at an average price of 90 cents. EVINE Live has a market cap of $74.26 million, and its shares were traded at $1.28 Tuesday. The company has a P/S ratio of 0.12.
EVINE Live announced its 2015 fourth-quarter results with revenues of $162.26 million and gross profit of $55.91 million; the net loss was $5.18 million. The 2015 total revenue was $674 million, a 5% increase from the 2014 total revenue. The 2015 gross profit was $245.05 million, a 7% increase from the 2014 gross profit. The 2015 net loss was $1.38 million.
On April 1, Director Thomas D. Beers bought 61,963 shares at an average price of $1.17. The price of the stock has increased by 11.11%. On March 31, Director Lowell W. Robinson bought 5,000 shares at an average price of $1.12. The price of the stock has increased by 16.07%. On March 30, Director Landel C. Hobbs bought 20,000 shares at an average price of $1.06. The price of the stock has increased by 22.64%.
